All posts by Iain Wilkie
Associate Analyst
Sectors Covered: Healthcare, Biotechnology, Medical Devices
By Iain Wilkie
30 March 2021, 4:00 PM
Morgans analyst Iain Wilkie speaks with Chief Executive Officer and Managing Director of ResApp (ASX:RAP), Tony Keating. Tony provides an update on a number of recent news events.
Read more...
By Iain Wilkie
17 November 2020, 11:00 AM
Morgans analyst Iain Wilkie chats to Dr Sean Hall who is the CEO and MD of drug development company Medlab Clinical (ASX:MDC) on some recent news and upcoming catalysts.
Read more...